IMN || Conferences

Eccentric exercise tamed elevated liver enzymes

Posted on: 15/05/2014 - 15:55

WASHINGTON – Eccentric exercise in the form of downhill walking is a promising new means of reducing elevated liver enzyme levels in overweight and obese sedentary individuals. This finding...

Field of Interest: Gastroentero...

Type: News Item

Eluxadoline scores in phase III for irritable bowel syndrome

Posted on: 12/05/2014 - 20:40

CHICAGO – A first-in-class oral drug targeting diarrhea-predominant irritable bowel syndrome achieved its primary and secondary endpoints in a pair of large phase III trials presented at the annual...

Field of Interest: Gastroentero...

Type: News Item

Phase III study: Prucalopride eases severe chronic constipation in men

Posted on: 12/05/2014 - 19:55

CHICAGO – Prucalopride, a high-affinity serotonin 5-hydroxytryptamine4 receptor agonist, proved effective for the treatment of severe chronic constipation in men in a phase III clinical trial. In...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Acupuncture beats propofol for endoscopy analgesia

Posted on: 08/05/2014 - 20:50

CHICAGO – Endoscopic ultrasound can be a long, uncomfortable, and even painful procedure. But electroacupuncture starting 45 minutes before the procedure significantly decreased the need for drugs to...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: PCPs fuzzy on HCC surveillance in cirrhosis

Posted on: 08/05/2014 - 17:00

CHICAGO – Several medical societies recommend that patients with cirrhosis undergo ultrasound surveillance for hepatocellular carcinoma every 6 months, but studies suggest less than 20% receive...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

Posted on: 07/05/2014 - 19:30

CHICAGO – The oral drug duo of sofosbuvir and ribavirin produced good cure rates in a study of 419 patients with hepatitis C genotype 2 or 3. Dr. Bruce R. Bacon, who was not involved in the study,...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Oral drugs tackle hepatitis C genotypes 2, 3

Posted on: 07/05/2014 - 19:30

Field of Interest: Endocrinology

Type: News Item

Sofosbuvir-ribavirin treats hepatitis C virus genotypes 2, 3

Posted on: 05/05/2014 - 18:05

CHICAGO – Oral sofosbuvir and ribavirin given for 12 weeks produced a sustained virologic response in 93% of 250 patients with hepatitis C virus genotype 2 and in 85% of patients with genotype 3...

Field of Interest: Gastroentero...

Type: News Item

Sofosbuvir-ribavirin treats hepatitis C virus genotypes 2, 3

Posted on: 05/05/2014 - 18:05

CHICAGO – Oral sofosbuvir and ribavirin given for 12 weeks produced a sustained virologic response in 93% of 250 patients with hepatitis C virus genotype 2 and in 85% of patients with genotype 3...

Field of Interest: Infectious diseases

Type: News Item

Initial dilation no help in eosinophilic esophagitis

Posted on: 05/05/2014 - 14:35

CHICAGO – Esophageal dilation combined with standard medical management of eosinophilic esophagitis doesn’t provide added benefit over medication alone in terms of dysphagia relief, according to a...

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters